Channel 1
Educational session
Date
20.11.2020
Time
15:35 - 16:55
Location
Channel 1
Chairs
- John B. Haanen (Amsterdam, Netherlands)
- Shigehisa Kitano (Tokyo, NY, Japan)
What are the most exciting new developments in immunotherapy of cancer? (ID 34)
Educational session
Neoadjuvant immunotherapy: Why does it work better? (ID 172)
Lecture Time
15:35 - 15:50
Speakers
- John B. Haanen (Amsterdam, Netherlands)
Location
Channel 1, Virtual Meeting, Virtual Meeting, Singapore
Date
20.11.2020
Time
15:35 - 16:55
What are the most exciting new developments in immunotherapy of cancer? (ID 34)
Educational session
CAR-T in solid cancer: What are the hurdles? (ID 173)
Lecture Time
15:50 - 16:05
Speakers
- Shigehisa Kitano (Tokyo, NY, Japan)
Location
Channel 1, Virtual Meeting, Virtual Meeting, Singapore
Date
20.11.2020
Time
15:35 - 16:55
What are the most exciting new developments in immunotherapy of cancer? (ID 34)
Educational session
Combining immunotherapy and angiogenesis inhibition: Is there synergy? (ID 174)
Lecture Time
16:05 - 16:20
Speakers
- Solange Peters (Lausanne, Switzerland)
Location
Channel 1, Virtual Meeting, Virtual Meeting, Singapore
Date
20.11.2020
Time
15:35 - 16:55
What are the most exciting new developments in immunotherapy of cancer? (ID 34)
Educational session
Intratumoral immunotherapy: For whom? (ID 175)
Lecture Time
16:20 - 16:35
Speakers
- Jonathan Cebon (Heidelberg, Australia)
Location
Channel 1, Virtual Meeting, Virtual Meeting, Singapore
Date
20.11.2020
Time
15:35 - 16:55
What are the most exciting new developments in immunotherapy of cancer? (ID 34)
Educational session
LIVE Q&A (ID 176)
Lecture Time
16:35 - 16:50
Speakers
- John B. Haanen (Amsterdam, Netherlands)
Location
Channel 1, Virtual Meeting, Virtual Meeting, Singapore
Date
20.11.2020
Time
15:35 - 16:55